Kaufusi Diagnosed with Hodgkin's Lymphoma
PROVO -- BYU sophomore forward Alexis Kaufusi has been diagnosed with Hodgkin’s Lymphoma, and will not compete for the women’s basketball team the remainder of the season.
She’s played in a total of 20 games this year averaging 4.9 points and 2.8 rebounds. Kaufusi is undergoing additional testing to determine the best course of treatment.
“Our thoughts and prayers are with Alexis and her family at this time,” said head coach Jeff Judkins. “We wish her a quick recovery and want her to know that she has our love and support.”
Hodgkin's Lymphoma is a cancer of the lymphatic system, which is part of the immune system. Advances in diagnosis and treatment of Hodgkin's Lymphoma have helped to make this form of cancer highly treatable, with the potential for full recovery.
The family wishes to express their appreciation for all the support, well wishes and prayers during this time.
As a freshman in 2009-10, Kaufusi played in all 33 games averaging 16 minutes of playing time. She ranked first on the team in field goal percentage, recorded 10 double figure scoring games and posted two double-doubles.
For more information about Hodgkin’s Lymphoma,
Recent Stories
BYU's big fourth quarter downs Dons 66-56, Cougars advance to WCC semifinal
Despite its top two scorers for the game on the bench with foul trouble, BYU outlasted any comeback attempts and beat…
BYU to face San Francisco for spot in WCC semi-final
BYU women's basketball will take on San Francisco at 1 p.m. in the quarterfinals of the 2023 University Credit Union…